Marketa Tomkova
marketatomkova.bsky.social
Marketa Tomkova
@marketatomkova.bsky.social
Group Leader at the Ludwig Cancer Research Institute, University of Oxford. Excited about cancer genomics, epigenomics, omics data integration, interdisciplinary and collaborative research. Mutational and non-mutational/epigenetic cancer driver mechanisms.
Please share: we’re recruiting a postdoctoral fellow – applications open until September 15!

To lead genomics data analysis of an exciting translational project in sAML cancer, supportive environment, and access to unique in-house technologies.

my.corehr.com/pls/uoxrecru...
Job Details
my.corehr.com
September 5, 2025 at 11:50 AM
What is the most common type of mutations, causing cancer and genetic diseases? C to T mutations in CpGs: Signature 1.

What is the best understood mutational signature? Signature 1. Or is it?

An intro thread about a paper we published last year... 🧵1/
www.nature.com/articles/s41...
Human DNA polymerase ε is a source of C>T mutations at CpG dinucleotides - Nature Genetics
A new method called polymerase error rate sequencing (PER-seq) can measure the nucleotide misincorporation rate of DNA polymerases. DNA polymerase ε mutants produce an excess of CpG<TpG errors duri...
www.nature.com
April 28, 2025 at 9:24 PM
We are recruiting! Senior postdoc in computational cancer genomics/epigenomics @ludwigcancer.bsky.social @ox.ac.uk. Lead research into epigenetic drivers of secondary AML with rich omics data + strong clinical/wet-lab collaborations.
cutt.cx/YUoB
We look forward hearing from you!

#epigenetics #jobs
April 28, 2025 at 2:59 PM